×
About 7 results

Lung Cancer Screening (PDQ®)–Health Professional Version - NIH
https://www.cancer.gov/types/lung/hp/lung-screening-pdq
NIH

Lung Cancer Screening (PDQ®)–Health Professional Version

Non-Small Cell Lung Cancer Treatment (PDQ®)–Health Professional Version (NIH)
https://www.cancer.gov/types/lung/hp/non-small-cell-lung-treatment-pdq
NIH

NSCLC is any type of epithelial lung cancer other than small cell lung cancer (SCLC). The most common types of NSCLC are squamous cell carcinoma, large cell carcinoma, and adenocarcinoma, but there are several other types that occur less frequently, and all types can occur in unusual histologic variants.

Non-Small Cell Lung Cancer Treatment (PDQ®) Health Professional Version
https://www.ncbi.nlm.nih.gov/books/NBK65865/
NIH PDQ Cancer Information Summaries; PDQ Adult Treatment Editorial Board.

Jun 12th, 2019 - This PDQ cancer information summary for health professionals provides comprehensive, peer-reviewed, evidence-based information about the treatment of non-small cell lung cancer. It is intended as a resource to inform and assist clinicians who care for cancer patients. It does not provide formal guidelines or recommendations for making health care...

Lung Cancer Prevention (PDQ®)–Health Professional Version
https://www.cancer.gov/types/lung/hp/lung-prevention-pdq?cid=eb_govdel
NIH - National Cancer Institute;

Mar 11th, 2020 - Lung cancer risk is largely a function of older age combined with extensive cigarette smoking history. Lung cancer is more common in men than women and in those of lower socioeconomic status. Patterns of lung cancer according to demographic characteristics tend to be strongly correlated with historical patterns of cigarette smoking prevalence. An except...

Breast Cancer Treatment (Adult) (PDQ®)–Health Professional Version
https://www.cancer.gov/types/breast/hp/breast-treatment-pdq

Oct 3rd, 2019 - Breast cancer is the most common noncutaneous cancer in U.S. women, with an estimated 62,930 cases of in situ disease and 268,600 cases of invasive disease in 2019.[1] Thus, fewer than one of six women diagnosed with breast cancer die of the disease. By comparison, it is estimated that about 66,020 American women will die of lung cancer in 2019. Men account fo...

Non-Small Cell Lung Cancer Treatment (PDQ®)–Health Professional Version
https://www.cancer.gov/types/lung/hp/non-small-cell-lung-treatment-pdq?cid=eb_govdel
NIH - National Cancer Institute;

Mar 12th, 2020 - NSCLC is any type of epithelial lung cancer other than small cell lung cancer (SCLC). The most common types of NSCLC are squamous cell carcinoma, large cell carcinoma, and adenocarcinoma, but there are several other types that occur less frequently, and all types can occur in unusual histologic variants. Although NSCLCs are associated with cigarette smoke, adenocarci...

Small Cell Lung Cancer Treatment (PDQ®)–Health Professional Version
https://www.cancer.gov/types/lung/hp/small-cell-lung-treatment-pdq?cid=eb_govdel
NIH - National Cancer Institute;

Mar 9th, 2020 - SCLC accounts for approximately 15% of bronchogenic carcinomas. At the time of diagnosis, approximately 30% of patients with SCLC will have tumors confined to the hemithorax of origin, the mediastinum, or the supraclavicular lymph nodes. These patients are designated as having limited-stage disease (LD). Patients with tumors that have spread beyond the supraclavicular areas are said to have ext...